BRAIN Biotech AG
XETRA:BNN
BRAIN Biotech AG
Total Current Liabilities
BRAIN Biotech AG
Total Current Liabilities Peer Comparison
Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
BRAIN Biotech AG
XETRA:BNN
|
Total Current Liabilities
€13.4m
|
CAGR 3-Years
7%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
Wacker Chemie AG
XETRA:WCH
|
Total Current Liabilities
€1.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Evonik Industries AG
XETRA:EVK
|
Total Current Liabilities
€4B
|
CAGR 3-Years
11%
|
CAGR 5-Years
4%
|
CAGR 10-Years
1%
|
|
Covestro AG
XETRA:1COV
|
Total Current Liabilities
€3.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
AlzChem Group AG
XETRA:ACT
|
Total Current Liabilities
€82.6m
|
CAGR 3-Years
11%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
Symrise AG
XETRA:SY1
|
Total Current Liabilities
€936.6m
|
CAGR 3-Years
13%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
10%
|
See Also
What is BRAIN Biotech AG's Total Current Liabilities?
Total Current Liabilities
13.4m
EUR
Based on the financial report for Dec 31, 2023, BRAIN Biotech AG's Total Current Liabilities amounts to 13.4m EUR.
What is BRAIN Biotech AG's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
4%
Over the last year, the Total Current Liabilities growth was -31%. The average annual Total Current Liabilities growth rates for BRAIN Biotech AG have been 7% over the past three years , 4% over the past five years .